Intelligent Bio Solutions Inc. Form 8-K Filing

Intelligent Bio Solutions Inc. (the "Company") entered into a Securities Purchase Agreement on August 31, 2026, with a single institutional investor to sell approximately $5.0 million in a private placement. The offering included common stock or pre-funded warrants, and Series N-1 and Series N-2 warrants. The offering closed on September 2, 2026, with pre-funded warrants issued in lieu of common stock. The company intends to use the net proceeds for working capital and general corporate purposes. The company also entered into a Placement Agency Agreement with Ladenburg Thalmann & Co. Inc. for the offering.